Preparation of ambroxol hydrochloride carboxymethyl chitosan micropheres without burst release

African Journal of Pharmacy and Pharmacology

Volumn 5, Issue 8, 2011, Pages 1063-1069

  Liu, Hongfei ^a   He, Yan ^b   Zhaoying, ^c   Ke, Peng ^d  

^a JIANGSU UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^c Shenyang Entry Exit Inspection and Quarantine Bureau   (China)

^d UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Ambroxol hydrochloride; Carboxymethyl chitosan; In vitro; Lung targeting; Microsphere

Indexed keywords

AMBROXOL; CARBOXYMETHYL CHITOSAN; CHITOSAN DERIVATIVE; LYSOZYME; MICROSPHERE; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; CROSS LINKING; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; IN VITRO STUDY; ION EXCHANGE; LIGHT SCATTERING; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; ULTRAVIOLET SPECTROPHOTOMETRY; X RAY DIFFRACTION;

EID: 80052470659     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Chen SC, Wu YC, Mi FL, Lin YH, Yu LC, Sung HW (2004). A novel pHsensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. J. Control Release, 96: 285-300.
2. Chuong MC, Christensen JM, Ayres JW (2009). Sustained Delivery of Intact Drug to the Colon: Mesalamine Formulation and Temporal Gastrointestinal Transit Analysis. Pharm. Dev. Technol., 141: 119-128.
3. Coppi G, Lannuccelli V, Leo E, Bernabei MT, Cameroni R (2001). Chitosan-alginate microparticles as a protein carrier. Drug. Dev. Ind. Pharm., 27: 393-400.
4. Harsha SRC, Rani S (2009). Ofloxacin targeting to lungs by way of microspheres. Int. J. Pharm., 380: 127-132.
5. Hollister LE (1989). Site-specific drug delivery to central nervous system. Neurobiol. Aging., 10: 628-631.
6. Hu YQ, Guo JX, Wang LJ, Tan RX, Zhen LY (2000). Preparation and evaluation of insulin-loaded polylactide microsphere using factorial design. Drug. Dev. Ind. Pharm., 26: 1309-1313.
7. Huo DJ, Deng SH, Li LB, Ji JB (2005). Studies on the poly (lactic-coglycolic) acid microspheres of cisplatin for lung-targeting. Int. J. Pharm., 289: 63-67.
8. Jenquin MR, McGinity JW (1994). Characterization of acrylic resin matrix films and mechanisms of drug-polymer interactions. Int. J. Pharm., 101: 23-34.
9. Jeong SH, Park K (2008a). Drug loading and release properties of ionexchange resin complexes as a drug delivery matrix. Int. J. Pharm.,http://www.sciencedirect.com/science/journal/03785173 361: 26-32.
10. Jeong SH, Park K (2008b). Development of sustained release fastdisintegrating tablets using various polymer-coated ion-exchange resin complexes. Int. J. Pharm., 353: 195-204.
11. Kumar N, Ravikumar MNV, Domb AJ (2001) Biodegradable block copolymers. Adv. Drug. Delivery. Rev., 53: 23-44.
12. Langer R (1990). New methods of drug delivery. Science, 249: 1527-1533.
13. Levy RJ, Labhasetwar V, Strickberger SA, Underwood T, Davis J (1996). Controlled release implant dosage forms for cardiac arrhythmias: Review and perspectives. Drug. Deliv., 3: 137-142.
14. Lu GY, Kong LJ, Sheng BY, Wang G, Gong YD, Zhang XF (2007). Degradation of covalently cross-linked carboxymethyl chitosan and its potential application for peripheral nerve regeneration. Eur. Polym. J., 43: 3807-3818.
15. Lu ZL, Chen WY, Hamman JH, Ni J, Zhai XL (2008). Chitosan-Polycarbophil Interpolyelectrolyte Complex as an Excipient for Bioadhesive Matrix Systems to Control Macromolecular Drug Delivery. Pharm. Dev. Technol., 13: 37-47.
16. Nahata T, Saini TR (2008). D-optimal designing and optimization of long acting microsphere-based injectable formulation of aripiprazole. Drug. Dev. Ind. Pharm., 34: 668-675.
17. Patel MM javascript:popRef('AF0001'), Shah TJ javascript:popRef('AF0001'), Amin AF,javascript:popRef('AF0001') ShahNN (2009). javascript:popRef('AF0002')Design, Development and Optimization of a 004Eovel Time and pH-Dependent Colon Targeted Drug Delivery System. Pharm. Dev. Technol., 14: 65-72.
18. Rao CGG, Motiwale AV, Satyanarayana D, Subrahmanyam EVS (2004). Formulation of taste masked oral microsphere of quinine sulphate by complexation. Indian. J. Pharm. Sci., 66: 329-331.
19. Ravikumar MNV, Kumar N (2001). Polymeric controlled drug delivery systems: Perspective issues and opportunities. Drug. Dev. Ind. Pharm., 27: 1-30.
20. Saito N, Okada T, Horiuchi H, Murakami N, Takakashi J, Nawata M, Ota H, Nozaki K, Takaoka K (2001). A biodegradable polymer as a cytokine delivery system for inducing bone formation. Nat. Biotechnol., 19: 332-335.
21. Sayin B, Somavarapub S, Li XW, Thanou M, Sesardic D, Alpar HO, senel S (2008). Mono-N-carboxymethyl chitosan (MCC) and Ntrimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery. Int. J. Pharm., 363: 139-148.
22. Soriano I, Delgado A, Kellaway I, Evora C (1996). Effect of surfactant agents on the in vitro release of insulin from DL-PLA microsphere. Drug. Dev. Ind. Pharm., 22: 109-1012.
23. Sriwongjanya M, Bodmeier R (1998). Effect of ion-exchange resins on the drug release from matrix tablets. Eur. J. Pharm. Biopharm., 11: 321-327.
24. Sultana Y, Mall S, Maurya DP, Kumar D, Das M (2009). Preparation and in vitro characterization of diltiazem hydrochloride loaded alginate microspheres. Pharm. Dev. Technol., 14: 321-331.
25. Ubaidulla Ujavascript:popRef('AF0001'), Khar RKjavascript:popRef('AF0001'), Ahmad FJ javascript:popRef('AF0001'), Tripathi Pjavascript:popRef('AF0002') (2009). Optimization of Chitosan Succinate and Chitosan Phthalate Microspheres for Oral Delivery of Insulin using Response Surface Methodology. Pharm. Dev. Technol., 14: 99-108.
26. Wang LP, Pei ZJ (2001). Therapeutic effect of ambroxol hydrochloride on chronic bronchitis after surgery. China Pharma., 4: 371-372.
27. Weerakody R, Peter F, Kosaraju SL (2008). Chitosan microspheres for encapsulation of _-lipoic acid. Int. J. Pharm., 357: 213-218.